anti-AADAC antibody product blog
Tags: Antibody; Polyclonal Antibody; AADAC; anti-AADAC antibody;
The AADAC aadac (Catalog #MBS2521562) is an Antibody produced from Rabbit and is intended for research purposes only. The product is available for immediate purchase. The AADAC Polyclonal Antibody reacts with Human, Mouse, Rat and may cross-react with other species as described in the data sheet. MyBioSource\'s AADAC can be used in a range of immunoassay formats including, but not limited to, ELISA (EIA), Western Blot (WB), Immunohistochemistry (IHC).WB: 1:500-1:2000
IHC: 1:25-1:100. Researchers should empirically determine the suitability of the AADAC aadac for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The AADAC aadac product has the following accession number(s) (GI #68299767) (NCBI Accession #NP_001077.2). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Please refer to the product datasheet for known applications of a given antibody. We\'ve tested the AADAC Polyclonal Antibody with the following immunoassay(s):
Western Blot (WB) (Western Blot analysis of Human fetal liver and liver cancer tissue using AADAC Polyclonal Antibody at dilution of 1:550)
Immunohistochemistry (IHC) (Immunohistochemistry of paraffin-embedded Human colon cancer using AADAC Polyclonal Antibody at dilution of 1:30)
Immunohistochemistry (IHC) (Immunohistochemistry of paraffin-embedded Human liver cancer using AADAC Polyclonal Antibody at dilution of 1:30)
Microsomal arylacetamide deacetylase competes against the activity of cytosolic arylamine N-acetyltransferase, which catalyzes one of the initial biotransformation pathways for arylamine and heterocyclic amine carcinogens. Arylacetamide deacetylation is an important enzyme activity in the metabolic activation of arylamine substrates to ultimate carcinogens. Displays major serine hydrolase activity in liver microsomes. Hydrolyzes also flutamide, which is an antiandrogen drug used for the treatment of prostate cancer that occasionally causes severe hepatotoxicity. Displays cellular triglyceride lipase activity in liver. Increases intracellular fatty acids derived from hydrolysis of newly formed triglyceride stores.
Immunogen: Recombinant protein of human AADAC
Calculated Molecular Weight: 46kDa. Buffer: PBS with 0.05% sodium azide, 50% glycerol, pH7.3. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing AADAC are readily searchable from our website. Different antibodies against the same target such as AADAC may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results. Carcinoma, Hepatocellular, Fatty Liver, Hepatitis, Liver Diseases, Liver Neoplasms are some of the diseases may be linked to AADAC Polyclonal Antibody. Adipose Tissue, Adrenal Gland, Connective Tissue, Intestine, Liver, Pancreas tissues are correlated with this protein.